000 01276 a2200361 4500
005 20250516033222.0
264 0 _c20110630
008 201106s 0 0 eng d
022 _a1097-6787
024 7 _a10.1016/j.jaad.2010.06.032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTintle, Suzanne
245 0 0 _aAzacitidine: a new medication associated with Sweet syndrome.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_cMay 2011
300 _ae77-9 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aAzacitidine
_xadministration & dosage
650 0 4 _aDrug Eruptions
_xetiology
650 0 4 _aEnzyme Inhibitors
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMyelodysplastic Syndromes
_xdrug therapy
650 0 4 _aRecurrence
650 0 4 _aSweet Syndrome
_xchemically induced
700 1 _aPatel, Vishal
700 1 _aRuskin, Andrea
700 1 _aHalasz, Charles
773 0 _tJournal of the American Academy of Dermatology
_gvol. 64
_gno. 5
_gp. e77-9
856 4 0 _uhttps://doi.org/10.1016/j.jaad.2010.06.032
_zAvailable from publisher's website
999 _c20762663
_d20762663